These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7095714)

  • 1. [Central motor and extrapyramidal side effects under therapy with antidepressants (author's transl)].
    Böning J
    Fortschr Neurol Psychiatr; 1982 Feb; 50(2):35-47. PubMed ID: 7095714
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acute drug-induced extrapyramidal syndrome: case studies of a decade at the autonomous toxicology department of the Arcispedale].
    Torrini M; Masini E; Ledda F; Mannaioni PF
    Clin Ter; 1981 Jun; 97(6):561-85. PubMed ID: 7023804
    [No Abstract]   [Full Text] [Related]  

  • 3. [Neuroleptic malignant syndrome. Beneficial effects of dantrolene on hyperthermia and hypertonia (author's transl)].
    de Rohan Chabot P; Elkharrat D; Conso F; Bismuth C; Goulon M
    Nouv Presse Med; 1982 Mar; 11(14):1067-9. PubMed ID: 7079122
    [No Abstract]   [Full Text] [Related]  

  • 4. [Psychopharmacotherapy: present status and trends].
    König L; Lange E
    Psychiatr Neurol Med Psychol (Leipz); 1979 Oct; 31(10):597-605. PubMed ID: 44747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical therapeutics. Psychotropic drugs.
    Steinhart MJ
    Am Fam Physician; 1975 Aug; 12(2):92-101. PubMed ID: 238380
    [No Abstract]   [Full Text] [Related]  

  • 6. Reactions to withdrawal of antidepressants, antiparkinsonian drugs, and lithium.
    Lawrence JM
    Psychosomatics; 1985 Nov; 26(11):869-74, 877. PubMed ID: 2867577
    [No Abstract]   [Full Text] [Related]  

  • 7. Extrapyramidal symptoms and antidepressant drugs: neuropharmacological aspects of a frequent interaction in the elderly.
    Govoni S; Racchi M; Masoero E; Zamboni M; Ferini-Strambi L
    Mol Psychiatry; 2001 Mar; 6(2):134-42. PubMed ID: 11317214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Psychometric effects of perphenacine below the "neuroleptic threshold" (author's transl)].
    Jacobi P; Maxion HH
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Dec; 8(6):366-74. PubMed ID: 1233531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine-related extrapyramidal side effects: a case report.
    Gallo M; Squarcione C; Bersani FS; Minichino A; Fojanesi M; Biondi M
    Riv Psichiatr; 2017; 52(4):172-173. PubMed ID: 28845867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurologic adverse manifestations and complications of ambulatory therapy with psychotropic drugs in the late stages].
    Makeeva VL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(2):178-82. PubMed ID: 636711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More data for the CYP2D6 hypothesis?: the in vivo inhibition of CYP2D6 isoenzyme and extrapyramidal symptoms induced by antidepressants in the elderly.
    García-Parajuá P; de Ugarte L; Baca E
    J Clin Psychopharmacol; 2004 Feb; 24(1):111-2. PubMed ID: 14709967
    [No Abstract]   [Full Text] [Related]  

  • 12. Adverse effects of tricyclic antidepressants: focus on the elderly.
    Glassman AH; Carino JS; Roose SP
    Adv Biochem Psychopharmacol; 1984; 39():391-8. PubMed ID: 6380230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse effects of tricyclic and non-tricyclic antidepressants.
    Beaumont G
    Int Clin Psychopharmacol; 1988 Nov; 3 Suppl 2():55-61. PubMed ID: 3063745
    [No Abstract]   [Full Text] [Related]  

  • 14. Tricyclic antidepressant-induced extrapyramidal side effects.
    Vandel P; Bonin B; Leveque E; Sechter D; Bizouard P
    Eur Neuropsychopharmacol; 1997 Aug; 7(3):207-12. PubMed ID: 9213080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety of fluoxetine--an update.
    Cooper GL
    Br J Psychiatry Suppl; 1988 Sep; (3):77-86. PubMed ID: 3074869
    [No Abstract]   [Full Text] [Related]  

  • 16. [Depressed patients and their treatment. Therapeutic mistakes and toxicity (author's transl)].
    Crome P
    Encephale; 1981; 7(4 Suppl):499-506. PubMed ID: 7318762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extrapyramidal symptoms associated with the adjunct of nortriptyline to a venlafaxine-valproic acid combination.
    Conforti D; Borgherini G; Fiorellini Bernardis LA; Magni G
    Int Clin Psychopharmacol; 1999 May; 14(3):197-8. PubMed ID: 10435776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Extrapyramidal side effects of neuroleptic and antidepressant treatment: assessment of potential risk factors through CYP2D6 genetic polymorphism].
    Reggiani K; Vandel P; Haffen E; Sechter D; Bizouard P; Vandel S
    Encephale; 2000; 26(1):62-7. PubMed ID: 10875063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug-induced extrapyramidal symptoms].
    Janzik HH
    Dtsch Med Wochenschr; 1975 Mar; 100(11):555-7. PubMed ID: 1116439
    [No Abstract]   [Full Text] [Related]  

  • 20. Monitoring antidepressant-induced cerebral hyperexcitability.
    Förstl H; Pohlmann-Eden B
    J Clin Psychiatry; 1993 May; 54(5):201-2. PubMed ID: 8509354
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.